The Board of LINK Medical has announced the appointment of Sissel Lønning Andresen as the company’s new CEO.
Ola Gudmundsen will remain in the company in a strategic role where he will work closely with Lønning Andresen, and support the Business Development and Commercial Operations team. He will remain an important owner of the company and continue to serve on the board of LINK Medical, states the company.
“I’m confident that Sissel will lead LINK Medical forward into the next phase of development. Sissel will further strengthen LINK Medical’s position as the leading Northern European CRO and capture the many exciting opportunities ahead of us,” says Ola Gudmundsen.
Sissel Lønning Andresen
Sissel Lønning Andresen has a Master of Science in pharmacy and has been working in the pharmaceutical industry since 1998, holding several positions within regulatory, sales, marketing, market access, and public affairs. For the last nine years, she has been the CEO of Pfizer Norway. Prior to this, she held several different roles at Pfizer and has also worked at Pharmacia and GE Healthcare. Through her experience, Sissel has a thorough understanding of the pharma market in the Nordics, describes LINK Medical.
“I’m thrilled and humbled to start the role as new CEO of LINK Medical at such a pivotal time and look forward to meeting my new colleagues across all departments. LINK has a great reputation for delivering high-quality services to the life science industry, and together with the highly skilled staff we will build and develop the company into its next chapter of growth,” says Sissel Lønning Andresen.
Sissel Lønning Andresen will assume the position of CEO of the company as of January 1st, 2023.
Photo of Sissel Lønning Andresen: Elisabeth Klevstuen
